Over 111,000 people living with HIV in the Western Cape have not accessed care in the past two years, according to the Provincial Health Data Centre. Monday marked world Aids Day under the global theme “Overcoming Disruption, Transforming the AIDS Response.''
According to UNAIDS, 40.8 million people are living with
HIV worldwide, 1.3 million new infections occurred in 2024, and 9.2 million
people are still not accessing treatment.
South Africa has made progress, but gaps remain. In the
Western Cape, 89% of people know their HIV status, 73% are on treatment, and
84% of those on treatment are virally suppressed, as the Department of Health
aims to ‘Close the Gap’, which aims to re-engage thousands of people who have
stopped HIV or TB treatment.
“Closing the gap is our commitment to meet people with
dignity, offer support without judgment, and make every step of the care
journey as welcoming as possible,’’ said Mireille Wenger, Western Cape Health
and Wellness MEC.
The City of Cape Town says more than 90 000 people receive Antiretroviral
Therapy (ART) at its Health facilities - nearly 50 000 through the ART Club
system. By June 2026, 58% of ART patients at City facilities will be accessing
services at a site offering Six-Month Multi-Month Dispensing
MMC for Community Services & Health, Francine Higham,
said preventing new HIV infections remains a priority.
‘’The City continues to provide oral Pre-exposure
prophylaxis (PrEP) and looking ahead, the introduction of the six-monthly
injectable PrEP Lenacapavir at selected facilities next year will offer an
additional, long-acting prevention option to help curb new infections,’’ she
said.
At the end of June 2024, City clinics had 37 357 clients
remaining on PrEP; that figure increased to 51 277 by June 2025.
‘’As we commemorate World AIDS Day, the City reaffirms its
commitment to supporting resilient health services, empowering communities, and
ensuring that every person living with HIV can access the treatment, care and
dignity they deserve. The City also extends sincere thanks to all staff working
across its HIV programme, including their work and dedication to the National
Close the Gap Campaign,’’ said Francine Higham, Mayoral Committee Member for Community
Services and Health.
Deputy President Paul Mashatile says government is
committed to improving treatment outcomes, especially for children receiving
newer TB regimens, including a shorter four-month course. Commemorating World Aids Day in Limpopo, Mashatile marked 20 years since the introduction of life-saving
ARVs, which have dramatically reduced HIV mortality and vertical transmission.
He also noted South Africa’s role in the Global Fund Aid Replenishment Summit
alongside the UK.
Speaking in his capacity as the chairperson of the South
African National AIDS Council, Mashatile said South Africa will begin
administering a groundbreaking new HIV-prevention injection in the drug's first
public rollouts in Africa. Lenacapavir,
taken twice a year, has been shown to reduce the risk of HIV transmission by
more than 99.9 per cent, making it functionally akin to a potent vaccine.
Mashatile described Lenacapavir as not merely a scientific
breakthrough, but “a symbol of what becomes possible when science, political
will, and community demand meet at the same table”. He noted that the drug
holds profound promise for young women and girls who often cannot negotiate
condom use.
“It empowers adolescent girls navigating relationships
marked by power imbalances. It provides protection for key populations who face
stigma and discrimination. It supports workers and learners who struggle with
the burden of daily pill adherence,” Mashatile said.
Despite South Africa surpassing the first and third UNAIDS
95-95-95 targets, challenges remain in ensuring that people who are diagnosed
begin and stay on treatment. The UNAIDS
95-95-95 target aims for 95% of people living with HIV to know their status,
95% of those diagnosed to be on sustained antiretroviral therapy, and 95% of
those on ART to have a suppressed viral load. The country's current progress
stands at 96-80-97, compared to global figures of 95-85-92.
To address the treatment–initiation gap, Mashatile highlighted the national recovery initiative launched on 25 February 2025—the 1.1 million “Close the Gap” Treatment Acceleration Campaign.
“To close the 1.1 million gap and prepare for long-acting
prevention, we must critically examine our efforts towards marginalised
communities and our willingness to embrace new scientific advancements,” he
said.
Mashatile also welcomed the rollout of the Six-Month
Multi-Month Dispensing model, introduced by Health Minister Aaron Motsoaledi. This
model allows stable patients to collect a six-month supply of ARVs in a single
visit, reducing travel costs, decongesting clinics, and improving treatment
adherence.
Done By: Mitchum George



Comments